Liquidia Earnings Estimates, EPS & Revenue | NASDAQ:LQDA

Comments

Liquidia Corp Earnings Estimates

LQDANASDAQ

Trade with Public

$39.47

-1.93-4.66%

At close: Apr 17, 5:00 PM EST

$39.08

-0.39-0.99%

After Hours: 7:21 PM EST

Overview NewsEarningsOptions Analyst Ratings Insider Trades Short Interest Stock Report

Liquidia Earnings Estimates, EPS & Revenue | NASDAQ:LQDA

Liquidia (LQDA) is scheduled to report Q1 earnings on May 7, 2026. Analysts estimate EPS of $0.38 and quarterly revenue of $113.48M.

In the most recent quarter (Q4), Liquidia reported EPS of $0.15, missing estimates of $0.33 by 0.55%. Revenue came in at $92.02M, exceeding the estimate of $79.29M by 0.16%.

Over the last 4 quarters, Liquidia has averaged an EPS surprise of 0.43% and a revenue surprise of 0.89%.

Earnings Date

May 7

EPS Estimate

$0.380

Quarterly Revenue Estimate

$113.48M

Annual Revenue
(as of Dec 31)

$158.32M

Liquidia Earnings History

Analyze the earnings history of Liquidia using advanced sorting and filters.

Loading calendar...

Liquidia (LQDA) Earnings Per Share

The chart below shows Liquidia's reported EPS compared to analyst estimates over recent quarters.

Liquidia (LQDA) Revenue

The chart below shows Liquidia's reported revenue compared to analyst estimates over recent quarters.

FAQ

When is Liquidia (NASDAQ:LQDA) reporting earnings?

Liquidia (LQDA) is scheduled to report earnings on May 7, 2026. The last reported earnings were for reported on March 5, 2026 for Q4.

What were the latest earnings per share (EPS) for Liquidia (NASDAQ:LQDA)?

The Actual EPS was $0.15, which missed the estimate of $0.33.

What were Liquidia’s (NASDAQ:LQDA) revenues?

The Actual Revenue was $92.02M, which beat the estimate of $79.29M.

People Also Watch

Supernus Pharmaceuticals Inc

NASDAQ:SUPN

$51.38

-0.03%

Tarsus Pharmaceuticals Inc

NASDAQ:TARS

$67.47

0.34%

Phibro Animal Health Corp

NASDAQ:PAHC

$56.94

-0.22%

Terns Pharmaceuticals Inc

NASDAQ:TERN

$52.61

-0.08%

Axsome Therapeutics Inc

Ligand Pharmaceuticals Inc

NASDAQ:LGND

$231.73

-0.04%

Jazz Pharmaceuticals PLC

NASDAQ:JAZZ

$203.29

-0.07%

Liquidia Earnings Estimates, EPS & Revenue | NASDAQ:LQDA

Liquidia (LQDA) is scheduled to report Q1 earnings on May 7, 2026. Analysts estimate EPS of $0.38 and quarterly revenue of $113.48M.

In the most recent quarter (Q4), Liquidia reported EPS of $0.15, missing estimates of $0.33 by 0.55%. Revenue came in at $92.02M, exceeding the estimate of $79.29M by 0.16%.

Over the last 4 quarters, Liquidia has averaged an EPS surprise of 0.43% and a revenue surprise of 0.89%.

Earnings Date

May 7

EPS Estimate

$0.380

Quarterly Revenue Estimate

$113.48M

Annual Revenue
(as of Dec 31)

$158.32M